Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Total Current Liabilities ₹1,326 Cr₹1,698 Cr₹1,355 Cr₹1,022 Cr₹2,804 Cr

What is the latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹1,326 Cr based on Mar2023 Consolidated results.
Year Total Current Liabilities
Mar2023₹1,326 Cr
Mar2022₹1,698 Cr
Mar2021₹1,355 Cr
Mar2020₹1,022 Cr
Mar2019₹2,804 Cr

How is Total Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2023 ₹1,326 Cr
-21.91
Mar2022 ₹1,698 Cr
25.38
Mar2021 ₹1,355 Cr
32.55
Mar2020 ₹1,022 Cr
-63.55
Mar2019 ₹2,804 Cr -

Compare Total Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹38,818.9 Cr 17.8% 24.7% 77.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹112,990.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1% -2.4% 28.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

17.8%

24.7%

77.6%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses